NEXUS : listed in the Prime Standard increased its sales by 21.4 % and earnings (EBIT) by 20.0 % in 2015. As a result, NEXUS Group has continued its successful... (Villingen Schwenningen 22 March 2016)
March 22, 2016 at 03:52 am EDT
Share
In 2015, sales improved by 21.4 % from KEUR 80,147 to KEUR 97,269. Sales increased by 27.1 % and reached KEUR 89,521 (previous year: KEUR 70,442) in the Healthcare Software Segment. The Healthcare Service Segment recorded sales of KEUR 7,748 following KEUR 9,705 and consequently 20.2 % less than in the previous year. The international share of total business volume was 49.8 % (previous year: 38.4 %) and amounted to KEUR 48,465 (previous year: KEUR 30,766). The sales of the subsidiary NEXUS Nederland consolidated for the first time are included in the figures. The development of the Swiss franc also had a positive effect on sales in the amount of KEUR 2,986.
The Group result before taxes on profit (EBT) improved by 16.6 % from KEUR 8,243 to KEUR 9,612. The result before taxes and interest (EBIT) in the amount of KEUR 9,640 improved compared to the same period last year (KEUR 8,035) by 20.0 %. The EBITA increased by 25.4 % from KEUR 10,352 (2014) to KEUR 12,981. The EBITDA increased by 25.5 % to KEUR 18,884 (previous year: KEUR 15,044) during the reporting period. The Group annual surplus reached KEUR 7,777 (previous year: KEUR 8,108). The undiluted earnings per share reached 49 cents (previous year: 0.55 cents) (diluted: 48 cents; previous year: 0.55 cents).
The cash flow developed especially strongly in the reporting year. The cash flow from current business transactions reached KEUR 18,145 and consequently considerably surpassed the high value of the previous year of KEUR 11,594 (+56.5 %).
NEXUS AG had equity capital amounting to KEUR 89,060 as of 31 December 2015 (previous year: KEUR 75,812). Consequently, the equity capital rate is 68.7 % (previous year: 70.1 %). There are no significant bank liabilities. At the end of 2015, the company had cash resources at its disposal in the amount of KEUR 20,943 (previous year: KEUR 22,578). As a result, NEXUS AG has a sustainable and healthy balance sheet as well as sufficient capital for further financing of its European growth strategy.
At the annual general meeting on 13 May 2016, the Supervisory Board and the Executive Board will propose to pay a dividend of 14 cents per share.
Nexus AG issued this content on 22 March 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 22 March 2016 07:51:01 UTC
Original Document: http://en.nexus-ag.de/web/0/inter/index.php?art_id=dc_2016_03_22_5c8eebeb68a203f467
Nexus AG is a Germany-based developer of software for the health care sector. Among others, the Company provides Nexus/HIS, an information system that supports the administrative and medical/nursing areas in hospitals; Nexus/Obstetrics, a documentation software for pregnancies; is also focusing on digital pathology which controls the processes from material entry to billing; Nexus/Psychiatry, a solution for psychiatric institutions from treating patients to key figure management for institution management; CWD - Clinic WindData (E&L), a diagnostics software for the areas of endoscopy, cardiology, sonography and ophthalmology; Nexus/Home, an information system that features finance, resident and treatment management, as well as staff deployment, and Nexus/Curator, a Web-based knowledge database for quality management with document management in health care. The Company operates through subsidiaries in Austria, France, Spain, Switzerland, the Netherlands and Poland, among others.
NEXUS : listed in the Prime Standard increased its sales by 21.4 % and earnings (EBIT) by 20.0 % in 2015. As a result, NEXUS Group has continued its successful... (Villingen Schwenningen 22 March 2016)
NEXUS AG 
